← Back to headlines
ImmunityBio Stock Rallies After Raising $100M for Global Expansion
ImmunityBio (IBRX) shares rallied 15% following the firm's announcement that it has raised $100 million to fund its global expansion initiatives.
1 Apr, 06:48 — 1 Apr, 06:48
Sources
Showing 1 of 1 sources
